Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer: surviving on the edge.

William C Hahn1

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. william_hahn@dfci.harvard.edu

Cancer Cell
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.

Cell reports·2026
Same author

Editorial Expression of Concern: Creation of human tumour cells with defined genetic elements.

Nature·2026
Same author

CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer.

Oncotarget·2026
Same author

SMARCB1 missense mutants disrupt SWI/SNF complex stability and remodeling activity.

Nature communications·2026
Same author

Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network.

Molecular cell·2026
Same author

A neomorphic protein interface catalyzes covalent inhibition of RAS<sup>G12D</sup> aspartic acid in tumors.

Science (New York, N.Y.)·2025

Cancer cells develop through genetic changes that disrupt normal cell growth and survival pathways. Recent research explores how senescence and apoptosis regulation impacts cancer development and progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer originates from normal cells acquiring genetic alterations, leading to neoplastic phenotypes.
  • These alterations disrupt critical regulatory networks governing cell proliferation, growth, and survival.
  • Cancer cells exist in a delicate balance between uncontrolled proliferation, genomic instability, cell cycle arrest, and programmed cell death (apoptosis).

Framework:

  • Focus on regulatory networks controlling cell proliferation, growth, survival, and cell death.
  • Investigate the interplay between genomic instability, cell cycle arrest, and apoptosis in cancer.
  • Examine the role of senescence and apoptosis pathways in cancer development and progression.

Implementation:

  • The Beatson International Cancer Conference highlighted recent advancements in understanding cancer-related pathways.

Related Experiment Videos

  • Discussions centered on the molecular mechanisms regulating senescence and apoptosis.
  • Exploration of how these pathways influence the neoplastic transformation and behavior of cancer cells.

    • Implications:

    • Advances in understanding senescence and apoptosis offer new targets for cancer therapy.
    • Elucidating regulatory network perturbations provides insights into cancer's complex biology.
    • Continued research is crucial for developing effective strategies against cancer by targeting key regulatory pathways.